Skip to main content

Table 2 Healthy donors PBMC T-regulatory cell analysis

From: Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma

Subject

CD4+/CD52hi+Foxp3+%

CD4+/CD25hi+/CD39+%

1

83.7

39.3

2

88.2

30.2

3

80.2

76.9

4

88.2

89.0

5

97.7

76.1

6

89.7

69.0

7

95.9

96.7

Average

89.08

68.17

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us